LeMaitre Vascular, Inc. (LMAT:NASDAQ) closed at $84.31 on October 26, 2026, down 0.17% on the day. The stock trades 28.6% below its 52-week high of $118.01 and 7.8% above its 52-week low of $78.22. Over the past year, it lost 5.3%. LeMaitre Vascular, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 24, 2025, LMAT closed higher on 136 days (54%). Its best day was February 26, 2026 (+24.41%) and its worst was August 5, 2026 (-25.32%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove plaque from arteries in the leg. Further, it offers valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the...
Find more stocks like LMAT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.